February 12, 2026 · Form 4 insider transaction
Quart Barry D sold 2,690 shares of Kiniksa Pharmaceuticals Ltd. at $45.00 per share, a transaction worth $121.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.